Transformed Health System in Southeast Pennsylvania Through Multiple Transactions
Thomas Jefferson University, a longtime firm client based in Philadelphia, is transforming health care delivery and value through a number of combinations that have expanded Jefferson’s delivery model to patients.
In 2016, our experienced team of health care lawyers represented Jefferson in its combination with Aria Health and its acquisition of a controlling interest in Rothman Orthopaedic Specialty Hospital (ROSH). Our team led all aspects of both transactions, including negotiation of the definitive agreements, due diligence, corporate and regulatory requirements, and clearance from the Federal Trade Commission.
Jefferson’s combination with Aria Health created the largest health system in the five-county region of southeast Pennsylvania and southern New Jersey, while the acquisition of ROSH marks Jefferson’s ninth hospital in the region, and its first specialty hospital. The combined organization — Thomas Jefferson University and Jefferson Health — brings together 5,000 physicians and practitioners, 5,770 nurses, 23,000 employees, and 2,217 inpatient beds.
Our health care lawyers are also representing Jefferson in connection with several pending transactions, including the addition to Jefferson Health of Kennedy Health System, a three-hospital, southern New Jersey-based health system. Additionally, we are representing Jefferson in its combination with Philadelphia University, which will create a comprehensive university that delivers high-impact education and value for students in health, science, architecture, design, fashion, business, and engineering.
Recovered Billions for Creditors in Groundbreaking Litigation against Caesars
The Corporate Restructuring Group successfully represented a group of hedge funds in a groundbreaking litigation against Caesars Entertainment Corporation arising from Caesars’ attempts to avoid payment on billions of dollars of corporate debt.
Over a two-year period, our lawyers handled litigation actions in multiple jurisdictions including a suit in the Southern District of New York and a multibillion-dollar bankruptcy filed in the Northern District of Illinois (one of the largest on record).
At the heart of these cases were arguments developed by Drinker Biddle based on the Trust Indenture Act, a Depression-era statute intended to protect minority bondholders.
In the midst of briefing an appeal of one of the issues in the case, Caesars agreed to a settlement that provided our clients with a recovery that is 72 percentage points higher than Caesars' initial offer, along with the payment in full of all attorneys’ fees and costs incurred by our clients in litigation.
Led Joint Ventures to Create One of the Greenest Commercial Properties in the U.S.
In 2016, Normandy Real Estate Partners and an OVG Real Estate/Normandy Real Estate Partners joint venture were involved in two separate property transactions relating to the 52-acre, 700,000-square-foot Unilever corporate headquarters in Englewood Cliffs, New Jersey.
In the first set of transactions, our Real Estate Group represented Normandy in the acquisition and leaseback to Unilever of the R&D portion of the headquarters property. This transaction also included establishing a condominium regime for the property and the sale of one of the condominium units (under long-term leaseback to Unilever) to an institutional investor, while positioning the balance of the property (under short-term leaseback to Unilever) for future development.
In the second set of transactions, we represented the OVG/Normandy joint venture in connection with the purchase and leaseback of the other Unilever headquarters property, with a separate transaction assigning the purchase contract simultaneously with the closing to a third-party institutional investor. The OVG/Normandy transaction also involved the negotiation of a development agreement under which OVG/Normandy is undertaking a major renovation and expansion of the Unilever headquarters property, which is anticipated to make the facility among the greenest and smartest commercial properties in the United States.
Coordinated Complex, Cross-Border Deals for Global Insurance Group
Enstar Group Limited, a public Bermuda insurance group with global operations, turned to our Corporate Group to lead it through a broad array of complex insurance merger and acquisition deals in 2016.
Two transactions stood out, the first of which was a $1.1 billion collateralized reinsurance transaction in which a Bermuda Enstar subsidiary reinsured 50 percent of certain workers' compensation, construction defect, and asbestos, pollution and toxic tort business from an Allianz subsidiary in Germany (originally held by Allianz’ U.S. subsidiary, Fireman's Fund Insurance Company).
In the second transaction, we advised Enstar in connection with a $919 million collateralized reinsurance transaction. In this transaction, a Bermuda subsidiary of Enstar assumed from a Bermuda subsidiary of QBE Insurance Group Limited, an Australian public company, certain workers’ compensation, construction defect and general liability business originally held by various QBE subsidiaries in the U.S.
Both of these complex, cross-border deals required highly skilled work and coordination among many lawyers in our Philadelphia, New York and Chicago offices.
Cutting-Edge Transactions at the Intersection of Insurance and Health Care
In 2016, Johns Hopkins HealthCare LLC, a subsidiary of Johns Hopkins Medicine, sold a minority stake in Hopkins Health Advantage, its Medicare Advantage health insurer subsidiary, to six of the largest and most prominent health systems in Maryland. Our Corporate and Health Care groups represented John Hopkins HealthCare LLC in this transformative transaction, which signals the new emphasis health care systems are placing on taking insurance risk, and how insurance ventures can be used to further not only commercial insurance interests, but also strategic alignment interests as well.
The transaction involved an intricate deal structure starting with the creation of a new insurance holding company, to which Johns Hopkins contributed Hopkins Health Advantage, and culminated in the sale of a minority stake in the holding company to the six regional health systems. The transaction also required the negotiation of new provider agreements with each health system. This challenging transaction presented a host of highly complex business, corporate and regulatory issues, which our team successfully navigated at the intersection of insurance and health care.
Obtained Unanimous International Trade Decision to Impose Tariffs on Chinese Specialty Fabric
With the future of its business at stake in a tug of war on fabric pricing, Auburn Manufacturing, Inc. turned to the Customs and Trade practitioners in our Government and Regulatory Affairs Group for help. Our lawyers successfully persuaded the International Trade Commission (ITC) to vote unanimously in Auburn’s favor, resulting in five years of significant duties on Chinese importers and opening up substantial new business opportunities for Auburn.
U.S. imports of silica fabric from China had been decimating Auburn’s business in all of its market segments. We filed an anti-dumping and countervailing duties petition with the U.S. Department of Commerce (DOC) and ITC in January 2016, alleging that imports of Chinese silica fabric were materially injuring the U.S. fabric industry.
The DOC handed down an affirmative preliminary anti-dumping determination in August 2016, which found that Chinese exporters were selling competing goods in the U.S. at less than fair value. The anti-dumping duties imposed by the DOC were retroactively applied back to early June in order to offset the surge in those imports. Additionally, the DOC imposed countervailing duties to offset unfair subsidies provided by the Chinese government. The total combined anti-dumping and countervailing duties imposed by the DOC ranged from approximately 200 percent to 300 percent, depending on the Chinese company.
As a result of the final ITC ruling, the DOC’s duties will remain in effect for at least five years. Since the imposition of the duties, Auburn’s business has begun to recover, allowing Auburn to rehire U.S. workers. This victory is a powerful remedy for other U.S. producers that are being adversely impacted by foreign imports.
Navigated Fund Complex Through Comprehensive Overhaul of Money Market Fund Regulations
In 2014, the Securities and Exchange Commission adopted the most comprehensive overhaul of money market fund regulation ever undertaken by the agency — all of which had become effective by November 2016.
While many mutual fund groups suffered substantial losses or were liquidated in the wake of new money market fund regulations, the Northern Funds Complex retained and gained assets. Our Investment Management Group assisted Northern Trust Investments, investment adviser to the Northern Funds Complex, on strategic discussions and in restructuring the fund lineup to comply with the new rules. Northern Funds was in the top 10 of all money market funds, as measured by assets, after the changes were complete.
Our work for Northern Funds included: filing registration statements and supplements with the SEC in 2016 to substantially revise disclosure about the funds and to convert their shareholder bases to comply with the rule; liquidating money market funds and several share classes that were expected to lose substantial assets as a result of shareholders migrating to other money market funds in the complex; advising the two fund boards on policies and procedures for imposing liquidation fees and redemption gates on the funds and developing compliance policies and procedures related to the reforms; reorganizing the funds’ retail fund shareholders to only include natural persons; and advising on fee reductions and related documentation.
Protected Business From Threat of Unfair Employee Raiding by Competitors
Under the threat of unfair employee raiding practices by multiple competitors, Freedom Mortgage Corporation turned to our Labor and Employment Group for help. We successfully obtained injunctions to stop these actions and continue to pursue claims against the competitors on our client’s behalf.
In one federal court case in New Jersey against Freedom Mortgage’s competitor AnnieMac Home Mortgage and 22 former Freedom Mortgage employees, we obtained injunctions prohibiting AnnieMac and the former Freedom Mortgage employees from calling on or doing business with any of Freedom Mortgage’s more than 2,000 wholesale mortgage division customers (mortgage brokers, banks and other financial institutions). The injunction also bars these parties from using or disclosing Freedom Mortgage confidential information. The injunction resulted in AnnieMac terminating the employment of almost all former Freedom Mortgage employees and electing to exit the wholesale mortgage market almost completely. We are now pursuing a sizable damages claim in that case.
In a second case, which is currently ongoing in New York state court, we obtained a preliminary injunction on behalf of Freedom Mortgage against its direct competitor Intercontinental Capital Group (ICG) and two former Freedom Mortgage employees. The preliminary injunction prohibits certain solicitation of our client’s employees by the former Freedom Mortgage employees.
Obtained Dismissal for Client Accused of Health Care Fraud
Near the end of a six-week trial, the United States Department of Justice dismissed with prejudice all seven felony counts against our client Maribel Tinimbang, the owner of a physical therapy company that provided services to three separate home health care providers.
Originally touted by then-Attorney General Loretta Lynch as a significant part of “the largest criminal health care fraud takedown” in the Department’s history, the indictment alleged that Ms. Tinimbang and her co-defendants orchestrated a massive $45 million fraud against Medicare through false claims, among other charges.
At trial, however, our lawyers successfully excluded key pieces of the government’s evidence before ultimately discovering that government lawyers had violated the criminal discovery rules. While the judge considered our lawyers’ requests for sanctions, the government agreed to dismiss all felony counts (including charges that were to be the subject of a second trial) against Ms. Tinimbang. In exchange, Ms. Tinimbang pleaded guilty to a single, unrelated misdemeanor charge, and received a sentence of 12 months’ probation and no fine. According to the Chicago Tribune, “the case fizzled in stunning fashion.”
Secured Summary Judgment in One of the Most Prominent Mass Tort Cases in U.S.
In one of the largest mass torts in the country, members of the Products Liability Group secured a significant victory on federal preemption in a California court.
Plaintiffs from five different states alleged that the label for a prescription medicine failed to properly warn about the risk of gynecomastia and should have instructed physicians to monitor blood prolactin levels. Plaintiffs asserted that the defendants knew of a "statistically significant association" between elevated prolactin and gynecomastia based on a data analysis that was generated for a journal article, but did not provide the analysis to the U.S. Food and Drug Administration (FDA) and omitted it from the published article.
In granting the defendants’ motion for summary judgment on all claims, the court held that the defendants satisfied their burden to demonstrate that they could not have implemented a label change without first obtaining approval from the FDA, and that the FDA would not have approved the plaintiffs' proposed label change based on the evidence.
The court concluded under the standards articulated by the Supreme Court that there was clear evidence that the FDA did not believe the warnings proposed by plaintiffs were appropriate, even though the particular data analysis had not been provided to the FDA. The court also found that the FDA's denial of a Citizens Petition requesting similar label changes, filed with the FDA by a plaintiff law firm, demonstrated clear evidence of the FDA's position.
The judge ruled in favor of our clients on the grounds that the plaintiffs' state law tort claims were preempted as a matter of federal law. The closely watched result has the potential to impact several thousand cases.
Led Defense in Closely Watched Hospital Antitrust Case
The proposed merger of Advocate Health Care Network, the largest health system in Illinois, with NorthShore University HealthSystem was one of the most closely watched combinations in the health care provider community since its announcement in 2014. The merger, which ultimately was challenged by the Federal Trade Commission (FTC) after an extensive investigation, would have created the largest integrated health system in the state of Illinois and the 11th largest nonprofit system in the country.
Our Health Care Competition Team represented Advocate throughout the investigation of the merger and subsequent litigation. After the FTC filed suit to block the merger, our team successfully defended Advocate in an eight-day preliminary injunction hearing in the spring of 2016 that culminated in U.S. District Judge Jorge L. Alonso’s finding “that plaintiffs have not met their burden of showing that there is a likelihood that they will succeed on the merits of their antitrust claims.” A federal appeals court, however, returned the case to the trial court for further findings and proceedings. Ultimately, on remand, the trial court ruled that the FTC had met its burden for a preliminary injunction pending the outcome of an FTC administrative hearing. At that point, having invested more than two-and-a-half years in the fight, Advocate and NorthShore terminated their affiliation agreement.
Advocate’s case challenged FTC orthodoxy in a number of areas of great importance to the industry, including the geographic parameters of health care markets, and the nature of merger-related efficiencies in an era of population health and provider risk-taking. The work of our defense team is expected to resound in future hospital merger cases.
Supported Beverage Manufacturer Expansion Into Higher-Margin Products
A longstanding client of the firm, Cott Corporation, is an NYSE- and TSX-listed beverage company incorporated in Canada and headquartered in Tampa, Florida. Since 2014, our team has represented Cott in M&A transactions valued at more than $1.6 billion, equity capital markets transactions valued at $300 million and related debt financing and integration matters. Over those years, we have also handled labor, contract and other disputes for Cott in various states and advised the company on branding and marketing.
In recent years, Cott has sought to diversify its historic private label carbonated soft drink business into higher-margin products including water, coffee, tea and filtration services. Cott turned to our Corporate, Litigation, Labor and Employment, and Intellectual Property groups to support its expansion efforts.
During 2016, we represented Cott in several acquisitions, financing matters and in a number of litigation matters. Our transactional work included the $355 million acquisition of S&D Coffee, a leader in custom coffee roasting and blending of iced tea for the U.S. foodservice industry, and the $45 million acquisition of Aquaterra, Canada's oldest and largest direct-to-consumer home and office water delivery business. We also advised Cott on the amendment and restatement of its $500 million global revolving credit facility. Our team was involved in the financing aspects of Cott’s €470 million acquisition of Eden Springs in Europe and managed a $150 million equity capital markets offering. When Cott faced contract disputes and labor matters, our Litigation and Labor and Employment groups assisted.
Cott also looks to Drinker Biddle to handle matters across several other practice groups, including benefits, environmental, customs and trade, and real estate.
Defended Financial Firm in FINRA Arbitrations and Litigation
Wells Fargo Advisors is a premier financial services firm that administers $1.5 trillion in client assets. It serves investors nationwide by providing advisory services, asset management, brokerage services, estate planning strategies, retirement planning, portfolio analysis and monitoring, and other financial services through more than 15,000 financial advisors.
Throughout 2016, our team of financial services litigation attorneys successfully represented Wells Fargo Advisors in numerous multimillion-dollar arbitrations before the Financial Industry Regulatory Authority, and in litigations before federal and state courts.
We defended Wells Fargo Advisors against claims of sales practice violations and claims by former employees of wrongful termination, defamation and/or discrimination. The team also prosecuted claims for the return of millions of dollars in loans made to employees secured by promissory notes and represented Wells Fargo in responding to regulatory agencies’ and self-regulatory organizations’ subpoenas and inquiries.
Continued Success in Inter Partes Review Proceedings Before the U.S. Patent Trial and Appeal Board
Inter Partes review (IPR) has become one of the hottest and most closely watched areas of patent law since its introduction. In September of 2012, the America Invents Act introduced Inter Partes Review as an alternative way for a party to efficiently challenge the validity of an issued patent at the U.S. Patent and Trademark Office. Our Intellectual Property Group is a leader in this important area of patent law, having obtained favorable results for clients in virtually all of the IPR cases we have handled.
As an example, in 2016, we successfully defended the patent rights of our client Hamamatsu Photonics K.K., in connection with an IPR petition filed by a competitor that challenged one of its key patents for a laser dicing process. We filed a response to the petition in October 2016 and, in parallel, filed four new continuation patent applications under the Track One expedited examination program, based on a pending continuation application relating to the challenged patent.
In December 2016, the Patent Trial and Appeal Board denied the competitor’s petition, preserving the validity of all 55 challenged claims of Hamamatsu’s patent. The four continuation applications we had filed were issued as patents around that same time, yielding four new patents in this key area of technology and strengthening the patent that our client’s competitor had originally challenged.
We have also used IPR petitions to challenge patents asserted against our clients. In 2016 we filed 14 petitions on behalf of Samsung Electronics, challenging the validity of five patents asserted against our client in litigation in Texas. Trial on those petitions against three of the five patents has already been granted based upon our showing of a reasonable likelihood of success in challenging the patents.
Redesigned Investment and Business Practices to Comply with the New Fiduciary Rule
In April 2016 the U.S. Department of Labor issued industry-changing regulations defining who is considered a fiduciary under the Employee Retirement Income Security Act of 1974 (ERISA). The new Fiduciary Rule, which contains an extraordinarily broad definition of a fiduciary coupled with new conditions in the associated prohibited transaction exemptions, will re-write the business practices for most financial service companies, particularly broker-dealers and insurance companies, if or when the rules become applicable.
Our ERISA Financial Services Team has been one of the go-to teams in the country when it comes to ERISA and has been working to help clients comply with the new requirements. While our team represented numerous banks, investment advisors, investment managers, broker-dealers, insurance companies, 401(k) record keepers, and other financial services companies, our work for national broker-dealer Edward Jones is notable. Edward Jones has approximately 14,000 advisors throughout the country — each of whom would be required to comply with the regulations.
Our ERISA Financial Services attorneys worked with Edward Jones’ lawyers and executives to redesign many of the company’s investment and business practices to comply with the new Fiduciary Rule. Throughout the year, our team addressed issues for Edward Jones related to various aspects of the investment company, securities regulation, ERISA and insurance laws, and the development or modification of their product and service offerings.
Representing Engineering Firm in Highly Publicized Flint Water Litigation
In a series of highly publicized class action and individual cases filed over the past year in Michigan arising from alleged lead poisoning due to consumption of water from the Flint River, Leo A. Daly Company and Lockwood, Andrews & Newnam, Inc. (LAN) turned to our experienced trial lawyers to defend them.
The water tragedy in Flint, Mich., has been the subject of extensive media coverage, both locally and nationally. The plaintiffs and media have suggested that LAN – an independent and highly regarded engineering firm – was somehow responsible for the quality of the water from the Flint River, which allegedly leached lead into the homes of residents. This is simply not the case since its design and engineering work was primarily limited to repairing the existing water treatment plant. Our lawyers have vigorously defended LAN and have been instrumental in providing detailed information to counteract the often inaccurate or incomplete reporting.
While still early in the litigation, to date, our trial lawyers have been named as lead counsel for all defendants in cases pending in Michigan state court, and have successfully secured dismissals of three of the class action cases against LAN, which were pending in the United States District Court – Eastern District of Michigan. Our team has also filed several more motions to dismiss in that court, as well as in state court, which remain pending at this time.
As would be expected in complex litigation such as this, our lawyers have not only been litigating at the trial court level but also in the Sixth Circuit. They have also recently filed a Writ of Certiorari in the Supreme Court over conflicts in various circuits interpreting the Class Action Fairness Act of 2005.
Class Actions Team Continues to Aggressively Defend TCPA Lawsuits
Our Class Actions Team defends leading companies in class action litigation in federal and state courts across the country. The team is comprised of litigators throughout our offices and has an outstanding record of success in obtaining dismissals, defeating class certification motions and, where appropriate, negotiating favorable individual and class-wide settlements.
In the past year, the surge in class action litigation under the Telephone Consumer Protection Act (TCPA) has continued. We are the go-to firm for aggressive representation of companies in these important, high-stakes matters. In the past two years, our Class Actions Team has represented clients in more than 100 TCPA matters with great success. In many instances, we have obtained dismissal of the claims with prejudice with no payment to the plaintiffs/claimants. We have prevailed on the merits, tendered cases for indemnification, negotiated favorable individual and class settlements (with non-monetary solutions where appropriate) and have aggressively pushed back on manufactured lawsuits.
In one such example, our team, through persistent and diligent fact investigation, demonstrated that the claims were manufactured. After our motion to compel arbitration was granted, we turned the tables and filed a motion for sanctions against the plaintiff’s attorney on behalf of our client. We obtained a favorable order that serves to remind plaintiffs’ attorneys of their obligation to conduct reasonable, pre-suit investigations and to dismiss claims that are found to be frivolous.
Our team’s experience and success in the defense of these actions is unparalleled. In addition, through a close collaboration with our regulatory lawyers, we advise clients on TCPA compliance, which is critically important given the evolving regulatory landscape and the present litigation climate.
Secured Jury Verdict Voiding Fraudulent Life Insurance Policies
In a case involving fraudulently-procured life insurance policies, a team of Philadelphia-based insurance litigators secured a jury verdict on behalf of our life insurer client in the Eastern District of Pennsylvania. The case arose following the disappearance of the insured in the Turks & Caicos Islands in June 2015. After a body purporting to be the insured’s was found in TCI’s Chalk Sound, the company commenced a fraud investigation and later filed a declaratory judgment action. The life insurance company claimed that the insured materially misrepresented his extensive medical history. The life insurance company also sought judicial declarations with respect the cause and manner of the insured’s death.
After a one-week trial, the jury reached a verdict in less than two hours, finding that the policies were procured through fraud and thus void ab initio. Shortly thereafter, the claimants dismissed their counterclaims for bad faith and punitive damages, which had been bifurcated from the jury’s consideration of fraud in the application.
Raised Awareness for Valve Disease among Congressional Policymakers
The District Policy Group, working in collaboration with the Alliance for Aging Research (Alliance), successfully advocated for the U.S. Department of Health and Human Services (HHS) to designate February 22 as National Heart Valve Disease Awareness Day. Working with the Alliance, federal policymakers, and other stakeholders for close to one year, the District Policy Group developed and implemented the strategy for the Alliance to secure this annual observance, during American Heart Month, as a unique opportunity to talk about heart valve disease and promote proper diagnosis and treatment. National Heart Valve Disease Awareness Day is centered on four key messages: listen to your body, know your risk factors, get your heart checked regularly, and spread the word and raise awareness.
The District Policy Group assisted the Alliance in a comprehensive approach that included collecting more than 20 national provider and patient advocacy organization endorsements for the HHS designation; ensuring introduction of a U.S. House Congressional Resolution, Congressional Record Statements, and floor speeches; and coordinating a Capitol Hill briefing event that featured the director of an NIH Institute and president of a national specialty society. These combined efforts helped generate significant press coverage and brought organizations, advocates, and individuals together in what will now be an annual opportunity to provide potentially life-saving information to millions of patients who may have heart valve disease.